Introduction
Important issues in transplantation of stem cells into the central nervous system that need to be solved to achieve restoration of function are adequate differentiation, survival, migration, and integration of transplanted cells. Furthermore, a major obstacle to transplantation of embryonic stem (ES) cells into the human brain is the formation of teratomas. In this chapter, we provide an overview on how cell adhesion molecules and extracellular matrix molecules can be applied to successfully modify ES cells for cell therapy approaches in animal models of neurological diseases, as both groups of recognition molecules provide important support to cells, participate in the control of cell development, and mediate cell survival both in vitro and in vivo. As an example from our own work, we describe how mouse ES cells that had been genetically modified to overexpress the neural cell adhesion molecule L1 or the extracellular matrix protein tenascin-R (TNR) promote several aspects of ES cell-mediated regeneration in animal models of neurological diseases. As a surface molecule on postmitotic neurons, L1 is expressed in the developing and adult central nervous system and has been shown to promote neuronal survival, neurite outgrowth, synapse formation, and cell migration. The extracellular matrix molecule TNR, on the other hand, is secreted by both subsets of neurons and myelinating oligodendrocytes in the postnatal brain, is a constituent of perineuronal nets, which promote cellular integrity and synaptic excitability of neurons, and can act as an attracting guidance molecule for migrating endogenous newborn neurons when ectopically expressed in vivo. Both L1 and TNR promote neuronal differentiation of ES cells in vitro and increase survival of ES cell-derived neurons after transplantation in the adult rodent brain. L1-overexpressing 151 al., 2004; Itsykson et al., 2005; Sonntag et al., 2007) , fibroblast factor 4 (FGF-4) to promote serotoninergic neuronal differentiation (Barberi et al., 2003) , a combination of retinoic acid (RA) and sonic hedgehog (Shh) to improve cholinergic motor neuron differentiation (Wichterle et al., 2002) or a combination of Shh and FGF-8, which has been shown to direct differentiation of ES cells from various species into dopaminergic neurons ; Lee et al., 2000; Perrier et al., 2004; Sanchez-Pernaute et al., 2008) . Finally, a lineage selection protocol has been established to generate a high number of FGF-2-responsive nestin-positive neural precursor cells from ES cells via so-called embryoid bodies by applying culture conditions, that favor the survival and proliferation of neural precursor cells but not of mesodermal and endodermal cell types (Okabe et al., 1996) . Embryoid bodies represent aggregates of differentiating ES cells that consist of a core of ectoderm, mesoderm and endoderm surrounded by visceral and parietal endodermal cells (Maye et al., 2000) and have been applied as model system to study early cell differentiation in vitro (Rohwedel et al., 1994; Wobus et al., 1997; Guan et al., 1999; Hegert et al., 2002; Hargus et al., 2008b) . The lineage selection protocol comprises 5 different stages and generates a high number of postmitotic neurons at the end of differentiation (Fig. 1 ). While this protocol has been optimized to enhance overall dopaminergic neuronal differentiation by the application of Shh and FGF-8 during stage 4 (Lee et al., 2000) , we have slightly modified this protocol to promote GABAergic differentiation of ES cells in vitro . Fig. 1 . Tenascin-R (TNR + ) and L1 (L1 + ) overexpressing mouse ES cells differentiate into βIII-tubulin-positive neurons (red) in vitro. The images in the upper row show cells at the end of differentiation using a 5-stage differentiation protocol, whereas images in the lower row show differentiated cells after prolonged cultivation in vitro, that form so-called substrateadherent embryonic stem cell-derived neural aggregates (SENAs). Both ES cell lines constitutively express green fluorescent protein (GFP; green) for better visualization after transplantation into animal models of disease. Images from Hargus et al., 2008 and Cui et al., 2010 with permission from Stem Cells and Brain Furthermore, by extending the time of culture at stage 4 for several weeks without passaging, we were able to derive three-dimensional neural aggregates that predominantly consist of postmitotic neurons and radial glial cells . These substrateadherent embryonic stem cell-derived neural aggregates (SENAs) can readily be isolated for transplantation and survive well after engraftment into the adult rodent brain Cui et al., 2010) . ES cells can be easily modified to overexpress genes of interest, which could have beneficial effects on the survival of ES cells and the differentiation of ES cells into certain cell lineages. Therefore, besides applying optimized differentiation protocols, several groups have overexpressed transcription factors in mouse and human ES cells in order to promote the differentiation of ES cells into particular neuronal subtypes. For example, overexpression of the transcription factor pitx-3 (Chung et al., 2005) or the LIM homeodomain transcription factor lmx1a (Friling et al., 2009) in mouse ES cells caused enhanced differentiation into midbrain dopaminergic neurons, which are the cell population at risk in Parkinson's disease. Similarly, mouse ES cells overexpressing the nuclear-receptor-related-factor-1 (nurr-1) showed enhanced differentiation into midbrain dopaminergic neurons in vitro and improved functional impairment after transplantation in an animal model of Parkinson`s disease .
The role of the cell adhesion molecule L1 and the extracellular matrix protein TNR during neuroectodermal differentiation of ES cells in vitro
Little is known about the effects of an overexpression of neural cell adhesion molecules or extracellular matrix (ECM) proteins in ES cells on their differentiation into postmitotic neurons and about their role in ES cell-mediated regeneration in animal models of neurological diseases. This is quite surprising, given that both groups of recognition molecules have important functions on cellular development and survival both in vitro and in vivo. Indeed, during embryogenesis but also during the entire postnatal life, the specification and integrity of cells is highly dependent on the communication of cells with their surrounding environment through transmembrane glycoproteins on neighboring cells (cell-cell interactions) or through soluble and structural components of the extracellular matrix (cell-matrix interactions). These properties of recognition molecules could have significant implications for cell replacement therapy approaches, since they may help to improve differentiation of ES cells in vitro and may support integration, survival and function of ES cell-derived cells after transplantation into animal models of disease. We have generated mouse ES cells that overexpress the recognition molecules L1 or TNR and have analyzed several effects of these molecules on ES cell-mediated regeneration in animal models of acute and chronic neurological disorders.
The effects of L1 on neuroectodermal differentiation of ES cells in vitro
L1 is a transmembrane cell surface molecule, which is expressed on postmitotic neurons in the central nervous system (CNS) and is found on Schwann cells in peripheral nerves (Lindner et al., 1983; Rathjen and Schachner, 1984; Moos et al., 1988; Kamiguchi and Yoshihara, 2001) . L1 is essential for the development of the central nervous system, as L1 promotes neuronal survival, neuronal migration and neurite outgrowth (Lemmon et al., 1989; Appel et al., 1993; Brummendorf et al., 1998; Kamiguchi and Yoshihara, 2001; Kleene et al., 2001) . A lack of L1 results in severe malformations within the CNS such as hydrocephalus or hypoplasia or even aplasia of fiber tracts including the corticospinal tract and the corpus callosum (Jouet et al., 1994) . Furthermore, L1-deficient mice have a reduced number of hippocampal neurons and anatomical malformations similar to those seen in patients have been described in these animals (Dahme et al., 1997; Demyanenko et al., 1999) . Besides its role during development, L1 has important functions in memory acquisition and is known to increase axon guidance and axon myelination after traumatic injury of the CNS and peripheral nervous system (Martini and Schachner, 1988; Zhang et al., 2000; Becker et al., 2004b) . When L1-overexpressing mouse ES cells were differentiated into neuroectodermal cells following the five stage differentiation protocol, the proportion of postmitotic neurons was significantly increased in vitro when compared to cultures consisting of differentiated mouse ES cells that had been transfected with an empty vector (WT ES cells; Bernreuther et al., 2006) . This pro-neuronal effect of L1 on cell differentiation, which happened at the expense of differentiation into astrocytic cells, is consistent with previous studies that showed increased neuronal differentiation of somatic neural stem cells when cultured on a surface coated with recombinant L1 (Dihne et al., 2003) or when genetically modified to overexpress L1 protein (own unpublished observations). This pro-neuronal effect could be attributed to homophilic interactions of L1. Furthermore, heterophilic cell-cell interactions through integrins, F3/contactin, NCAM, CD9, and CD24 on other neurons have been described for L1 as well as cell-matrix interactions (Silletti et al., 2000) , which could additionally account for the beneficial effects of L1 on neuroectodermal differentiation of ES cells in vitro. Notably, other neuronal surface molecules besides L1 have been shown to promote neuronal differentiation in vitro, which further supports the hypothesis that an overexpression of neuronal cell adhesion molecules in ES cells is a suitable approach towards their application in vivo. ES cells overexpressing the glycoprotein M6A, which is a cell adhesion molecule expressed on neurons in the CNS, differentiated more efficiently into neurons when compared to non-modified control ES cells (Michibata et al., 2009 ) and the L1-binding partner molecule NCAM significantly increased neuronal differentiation of embryonic neural precursor cells into mature neurons in vitro when added into medium of cultured cells (Shin et al., 2002) . However, in contrast to L1, the beneficial effects of ES cells overexpressing these molecules have not been tested in animal models of disease to date.
The effects of TNR on neuroectodermal differentiation of ES cells in vitro
TNR is an ECM protein and is almost exclusively expressed by oligodendrocytes and subpopulations of neurons in the CNS after birth. In white matter, TNR is located at nodes of Ranvier and internodes (ffrench-Constant et al., 1986; Bartsch et al., 1993) . In grey matter, TNR is detectable in perineuronal nets that surround inhibitory interneurons and motorneurons and which provide neuroprotective cues to these cells (Angelov et al., 1998; Bruckner et al., 2000; Dityatev et al., 2010) . Several, in part opposing functions have been described for TNR and therefore, this molecule was also named janusin adopted from the name of the Latin god Janus, the god with the two faces symbolizing ambivalence (for review see Schachner et al., 1994) . For instance, TNR acts as a repellent guidance molecule in the optic nerve of zebrafish (Becker et al., 2003) , but mediates the detachment of migrating cells from the RMS within the olfactory bulb in mice, establishing TNR also as an attracting guidance molecule (Saghatelyan et al., 2004) . Furthermore, TNR promotes neurite outgrowth in vitro when presented as a smooth substrate (Husmann et al., 1992; Norenberg et al., 1995) , but inhibits neurite outgrowth when presented as sharp substrate border (Becker et al., 2004a ).
Similar to L1-overexpressing ES cells, TNR-overexpressing ES cells showed an enhanced neuronal differentiation into postmitotic neurons at the end of differentiation when compared to differentiated mouse ES cells that had been transfected with an empty vector (WT ES cells; Hargus et al., 2008a) . It is currently not known why TNR promotes neuronal differentiation of ES cells in vitro but similarly to TNR, a pro-neuronal effect has also been described for tenascin-C, another member of the tenascin family of ECM molecules, which significantly increased neuronal differentiation of embryonic mesencephalic explant cultures when added to the cell culture medium (Marchionini et al., 2003) . Interestingly, TNR-deficient mice have reduced numbers of inhibitory interneurons in the motor and sensory cortex, which illustrates a pro-neuronal effect of TNR also in vivo (own unpublished observations). Notably, extracellular matrix molecules are widely used to promote the differentiation of ES cells into neuroectodermal cells. For example, current differentiation protocols recommend the application of fibronectin and laminin to ES cell-derived neural precursor cells (Lee et al., 2000) . Furthermore, culture of differentiating ES cells on substrate-bound poly-Lornithine or soluble Matrigel -a basement membrane extract consisting of collagen IV, heparin sulphate proteoglycans, entactin, and nidogen (Kleinman et al., 1986 ) -increases neuronal differentiation of ES cells in vitro (Goetz et al., 2006; Ma et al., 2008) . It should be mentioned, however, that also inhibiting effects of some extracellular matrix proteins on neuronal differentiation of ES cells have been described. Gelatine -a mixture of collagen components -increases astrocytic but significantly decreases neuronal differentiation of ES cells in vitro (Goetz et al., 2006) .
Application of differentiated ES cells and fetal cells in animal models of neurological diseases
Several studies have shown that the transplantation of differentiated and specialized neurons can lead to functional improvement in animal models of neurological diseases. For instance, neurons isolated from mouse or human embryonic mesencephalon have been widely used for transplantation in the 6-OHDA-lesion rodent animal model of Parkinson´s disease (Grealish et al. 2010; Brundin et al., 1986) , and human fetal cells from the ventral mesencephalon have also been used in several clinical trials in Parkinson patients, some of which showed significant clinical improvement (Mendez et al., 2005; Astradsson et al., 2008; Mendez et al., 2008; Lindvall and Kokaia, 2009) . Similarly, fetal striatal neurons have been successfully transplanted into animal models of Huntington´s disease to replace damaged GABAergic medium-sized spiny projection neurons in the host striatum (Isacson et al., 1986; Dunnett and Rosser, 2007) , and clinical trials have shown improvement in some of the transplanted patients suffering from Huntington's disease (Philpott et al., 1997; Dunnett and Rosser, 2004) . However, alternative cellular sources are required because of the limited availability of fetal tissue. Due to their ability to generate functional neurons at high numbers in vitro, ES cells constitute a promising cell population for such therapeutic approaches and have been applied in several animal models of neurological diseases after pre-differentiation into desired neuronal phenotypes in vitro. Several studies have shown that transplantation of mouse, primate or human ES cell-derived neural precursor cells or neurons can lead to functional improvement in animal models of Parkinson´s disease Kim et al., 2002; Ben-Hur et al., 2004; Roy et al., 2006; Sanchez-Pernaute et al., 2008; Yang et al., 2008; Cui et al., 2010) . Furthermore, differentiated mouse and human ES cells have been successfully applied in animal models of Huntington`s disease Dihne et al., 2006; Aubry et al., 2008; Hargus et al., 2008a) , stroke (Wei et al., 2005; Buhnemann et al., 2006; Oyamada et al., 2008) , and spinal cord injury Keirstead et al., 2005; Sharp et al., 2010) to improve different aspects of regeneration. Notably, the American Food and Drug Administration (FDA) has recently for the first time approved a clinical trial on the transplantation of human ES cell-derived oligodendrocyte progenitor cells in patients with acute spinal cord injury conducted by the Geron Corporation. In this context, however, it should be emphasized that the transplantion ES-cell derived cells is associated with a specific risk of teratoma formation due to the presence of undifferentiated ES cells in the cell suspension for transplantation, emphasizing the requirement for efficient cell differentiation in vitro and for thorough cell purification before engraftment. We will focus on this topic at the end of this chapter.
Transplantation of differentiated L1-overexpressing and TNRoverexpressing ES cells in animal models of acute and chronic neurological disorders
Several challenges are associated with transplantation of ES cell-derived neurons, which determine functional outcomes of a cell replacement therapy. Such critical aspects include an efficient differentiation of ES cells into desired neuronal phenotypes in vitro as described above, sufficient survival of donor cells after transplantation, and efficient integration of transplanted neurons within the host tissue in order to mediate functional graft-host communication. Several studies have described poor survival of ES cell-derived neurons and limited graft-host interactions after transplantation into the adult rodent striatum (Schulz et al., 2004; Yurek and Fletcher-Turner, 2004; Sonntag et al., 2007) and that survival of cells depends on time of injection after injury (Johann et al., 2007; Darsalia et al., 2010) . By overexpressing the recognition molecule L1 in ES cells, we found that in vitro-generated L1-overexpressing SENAs showed two-fold improved survival after transplantation into MPTP-treated Parkinsonian mice when compared to engrafted WT SENAs (Cui et al. 2010) . Furthermore, the L1-overexpressing SENAs contained an approximately two-fold increased number of dopaminergic neurons, and engrafted L1-overexpressing cells migrated 2.5× longer distances within the host striatum than wt cells. Also, transplanted L1-overexpressing SENAs rescued a higher number of endogenous imperilled midbrain dopaminergic neurons and improved functional recovery when compared to engrafted differentiated WT SENAs (Cui et al. 2010) . In two other studies, we applied the 5-stage differentiation protocol to L1-overexpressing and WT ES cells, which were transplanted into the quinolinic-acid mouse model of Huntington´s disease and into an animal model of acute spinal cord injury . In the former study, the L1-overexpressing grafts contained a higher number of surviving GABAergic neurons and L1-overexpressing cells migrated 3× longer distances within the host striatum when compared to WT cells. Importantly, L1-overexpressing ES cell-derived cells showed functional effects on apomorphine-induced rotational asymmetry in these quinolinic acid-lesioned animals in contrast to engrafted WT control cells . In line with these findings, differentiated L1-overexpressing ES cells showed robust survival and migrated up to 700 μm in an animal model of acute spinal cord injury, while only few differentiated WT ES cells survived the first few weeks after transplantation into the spinal cord .
Similar to L1-overexpressing ES cell grafts, transplants consisting of TNR-overexpressing ES cells, differentiated according to the 5-stage differentiation protocol, contained a two-to three-fold higher number of surviving GABAergic neurons in the quinolinic acid-lesioned mouse striatum when compared to WT ES cells (Hargus et al., 2008a) . However, in contrast to engrafted L1-overexpressing cells, TNR-overexpressing ES cells showed slightly decreased migration into the host striatum when compared to WT ES cells, but attracted host-derived neuroblasts from the subventricular zone (SVZ) and the rostral migratory stream (RMS) leading to the recruitment of host-derived newborn neurons within the grafted area (Hargus et al., 2008a) .
The influence of L1 and TNR on survival of transplanted cells
Most cells die shortly after transplantation into the adult brain and spinal cord probably due to hypoxia, reduced supply of trophic factors and immune responses. It has been proposed that also limited cell-cell and cell-matrix interactions account for cell death after transplantation into the CNS (Marchionini et al., 2003) . Indeed, cell apoptosis can be induced by lack of structural support from surrounding neighboring cells and from the extracellular environment (Raff, 1992; Meredith et al., 1993; Frisch and Francis, 1994) . This kind of apoptosis has been shown as early as during the trituration of neural stem cells in vitro prior to transplantation (Schierle et al., 1999) . Therefore, stable expression of surface or matrix molecules in engrafted cells might help to increase cell-cell contacts and cellular survival. Candidate molecules include NCAM and L1, since both recognition molecules have neuroprotective effects on dopaminergic neurons in vitro (Hulley et al., 1998; Ditlevsen et al., 2007) , and mechanisms for L1-mediated neuroprotection have been described, which include inhibition of caspase-3 and increased phosphorylation of extracellular signal-related kinases 1/2, Akt and Bad (Loers et al., 2005) . Increased L1-mediated cell-cell interactions in grafts could explain why L1-overexpressing cells contained a reduced number of caspasepositive apoptotic cells and an increased number of surviving dopaminergic neurons after engraftment into Parkinsonian mice (Cui et al. 2010) , and why L1-overexpressing ES cells survived after transplantation into the injured spinal cord while only few WT ES cellderived cells were detectable . Therefore, the microenvironment around grafted cells seems to further influence those mechanisms of cell survival, which are mediated by cell surface molecules. Since ECM proteins provide structural support to cells and may help to trap and store growth factors, several groups have analyzed the effect of co-delivery of cells and matrix proteins on the survival and function of these cells in the brain but also outside the CNS. When rat cardiomyoblasts were engrafted in collagen matrices into a rat model of myocardial infarction, larger grafts and an improved ventricular heart function were observed in these animals (Kutschka et al., 2006) . Similarly, human ES-cell derived cardiomyocytes survived better in infarcted rat hearts when co-delivered with a factorenriched Matrigel matrix (Laflamme et al., 2007) . The addition of the ECM protein tenascin-C to a single cell suspension of fetal mesencephalic neurons before transplantation significantly increased the survival of graft-derived dopaminergic neurons, when engrafted at low density in a rat model of Parkinson´s disease (Marchionini et al., 2003) . This study also showed that the cell density of engrafted cells is a critical parameter for the impact of co-delivered ECM molecules on the survival of implanted cells, as tenascin-C did not influence cell survival in grafts with high cell density. Using a similar high-cell-density approach, we could show that grafts consisting of differentiated TNR-overexpressing ES cells contained increased numbers of surviving GABAergic neurons in a mouse model of Huntington´s disease (Hargus et al., 2008a ) when compared to WT ES cells. However, this effect is most likely a result of the positive effect of TNR on the in vitro-differentiation of ES cells into postmitotic neurons rather than a result of increased cell survival (as similarly seen for L1 + grafts in the same animal model), since the graft sizes were not altered by the presence of TNR. It will be very interesting to determine how different densities of TNRoverexpressing ES cells for transplantation influence cell survival and function in this and other animal models of neurological diseases.
The role of the recognition molecules L1 and TNR on cell migration in animal models of neurological disorders
Successful outcomes of a cell therapy in neurological diseases depend on sufficient interaction of engrafted neurons with host-derived cells. Such interaction could lead to functional integration of graft-derived neurons into endogenous neuronal circuitries, mediate important structural and trophic support to imperilled host-derived neurons and result in the mobilization of endogenous host-derived neural progenitor cells, which in turn might support graft-mediated regeneration within the host brain. Enhanced migration of implanted cells into the host tissue could be beneficial for the integration of engrafted cells, since this process favors a higher degree of functional connectivity to host circuitries (Dunnett and Rosser, 2007) . It is well known that engrafted differentiated ES cells show only poor migration in the recipient brain in contrast to implanted fetal neural progenitor cells (Englund et al., 2002; Dunnett and Rosser, 2007) . By transplanting differentiated ES cells as SENAs instead of single cells, we could show that the migration of engrafted ES cells into the rodent striatum was significantly enhanced possibly due to the altered microenvironment provided by different cell-cell and cell-matrix interactions . Furthermore, an overexpression of L1 in engrafted ES cellderived cells resulted in significantly enhanced migration into the host striatum in both, MPTP-and quinolinic acid-lesioned Parkinsonian and Huntington mice Cui et al., 2010) . In addition, differentiated L1-overexpressing ES cells migrated rostrally and caudally from the lesion site when transplanted in an animal model of acute spinal cord injury, while WT ES cells remained at the injection site . Importantly, the engrafted L1-overexpressing cells showed close proximity to re-growing corticospinal tract axons, which were guided into and also beyond the lesion site in the injured spinal cord. Similar beneficial effects of L1 on axonal outgrowth of corticospinal neurons have been decribed after infusion of soluble Fc-tagged L1 into the lesioned spinal cord, which resulted in behavioral recovery in most of the L1-Fc-treated animals (Roonprapunt et al., 2003) . Overexpression of polysialic acid (PSA), a carbohydrate polymer attached to the neural cell adhesion molecule NCAM, which was achieved by transduction of ES cell-derived cells with retroviruses encoding the polysialyltransferase STX, modified the susceptibility of differentiated ES cells to cytokines after transplantation into the rodent brain thereby influencing migration (Glaser et al., 2007) . Since these PSA-expressing ES cells were transplanted into the striatum of healthy unlesioned rats, it is not known how these cells influence function in animal models of neurological diseases. However, such transplantation studies could be very promising given that PSA glycomimetica promote functional recovery in mice after peripheral nerve injury (Mehanna et al., 2009) and spinal cord compression (Mehanna et al. 2010) . ECM molecules can act as attractant or repellent guidance molecules and both functions have been described for TNR in vitro and in vivo (Schachner et al., 1994; Jones and Jones, 2000) . Differentiated TNR-overexpressing ES cells migrated shorter distances in vitro and after transplantation into the striatum of quinolinic acid-lesioned mice in vivo when compared to WT cells (Hargus et al., 2008a) . However, despite reduced migration of engrafted cells, TNR-overexpressing ES cells showed a tendency towards increased coverage with host-derived synaptic boutons (Hargus et al., 2008a) , reflecting increased synaptic input from host-derived neurons towards engrafted cells. This finding goes in line with the reduced density and abnormal structure of symmetrical synapses in TNR-deficient mice (Nikonenko et al., 2003; Apostolova et al., 2006) . The generally low degree of synaptic coverage of engrafted ES cell-derived neurons (less than 6% of all engrafted cells for both TNR-overexpressing and WT cells), could explain, however, why engrafted rats did not show reduction in apomorphine-induced rotational asymmetry (Hargus et al., 2008a) .
The role of the recognition molecules L1 and TNR on endogenous neurogenesis and neuroprotection in animal models of neurological disorders
The TNR protein secreted by implanted TNR-overexpressing cells had interesting positive effects on graft-host interactions, as host-derived doublecortin-positive neuroblasts were attracted by engrafted TNR-overexpressing ES cell-derived cells and migrated from the SVZ and the RMS towards and into the grafted area. This effect was sustained for at least 2 months after transplantation (Hargus et al., 2008a) . This attractant effect of ectopically presented TNR on endogenous migrating neuroblasts from the SVZ, that migrate toward the olfactory bulb but no other brain regions under physiological conditions (Luskin, 1993; Lois and Alvarez-Buylla, 1994 ), has been previously described after transplantation of nonneuronal TNR-overexpressing fibroblast-like cells into the adult forebrain in close proximity to the RMS (Saghatelyan et al., 2004) and is in line with the observations that TNR serves as a detachment signal for migrating cells in the adult olfactory bulb (Saghatelyan et al., 2004) and developing cerebellar cortex (Husmann et al., 1992) . Furthermore and in line with our observations on enhanced TNR-mediated neuronal differentiation of ES cells in vitro, we found that TNR-overexpressing ES cell-derived cells promoted the generation of newborn host-derived neurons in the grafted area, and the degree of this recruitment of endogenous neurons was three-fold higher than in grafts consisting of WT ES cell-derived cells (Hargus et al., 2008a) . It remains open to which extent a recruitment of migrating or in situ-generated host-derived neural precursor cells or newborn neurons supports regeneration in the adult lesioned brain. However, a recruitment of endogenous neural progenitor cells from the SVZ into lesioned areas has been described in several animal models after ischemic (Arvidsson et al., 2002; Nakatomi et al., 2002; Parent et al., 2002) , physical (Magavi et al., 2000) or excitotoxic (Tattersfield et al., 2004) brain lesions, and differentiation of these recruited precursor cells into neurons with adequate phenotypes has been shown in many of these studies (Magavi et al., 2000; Arvidsson et al., 2002; Nakatomi et al.; Parent et al., 2002) . In this context it should be noted, that other beneficial molecules including glial cell linederived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF) could also be considered for overexpression in ES cells to improve regeneration in animal models of neurological diseases. Indeed, intraventricular application of BDNF enhanced neurogenesis in the SVZ (Zigova et al., 1998) and induced migration of neural progenitor cells from the SVZ into adjacent non-neurogenic areas in the adult brain (Benraiss et al., 2001; Pencea et al., 2001) . Furthermore, both BDNF and GDNF are used in established protocols for the differentiation of human ES cells into dopaminergic neurons in vitro (Perrier et al., 2004; Sonntag et al., 2007; Cooper et al., 2010) and have neuroprotective effects on endogenous neurons in animal models of neurodegenerative diseases (Grondin and Gash, 1998; Zuccato and Cattaneo, 2009) . Interestingly, BDNF (Cassens et al. 2010) and GDNF (Nielsen et al., 2009 ) have been shown to be functionally connected to neural cell adhesion molecules and thus, beneficial effects of overexpression of these neurotrophins might be mediated by neural cell adhesion molecules and therefore, overexpression of cell adhesion molecules instead of neurotrophins might prevent potential adverse effects of neurotrophin overexpression such as induction of neuropathic pain (Geng et al., 2010) . Similar neuroprotective effects on endogenous host-derived neurons are mediated by the transplantation of neural stem cells into rodent animal models of Parkinson´s disease Yasuhara et al., 2006) or spinal cord injury (Teng et al., 2002) , probably due to neuroprotective factors secreted by engrafted cells. Interestingly, an overexpression of L1 in neural stem cells improved their distribution within the host midbrain and rescued about 1.5 x more host-derived imperilled dopaminergic neurons after transplantation into MPTP-lesioned transgenic L1-overexpressing Parkinsonian mice, when compared with engrafted WT neural stem cells (Ourednik et al., 2009 ). This finding demonstrates that a recognition molecule can positively influence survival of endogenous neurons and led us to analyze the effects of overexpression of L1 in engrafted differentiated ES cells on host-derived dopaminergic neurons in the MPTP-lesion mouse model of Parkinson´s disease (Cui et al. 2010 ). L1-overexpressing SENAs transplanted in close proximity to the substantia nigra increased the number of host-derived dopaminergic neurons and enhanced striatal dopamine levels after intrastriatal transplantation, demonstrating neuroprotective effects of L1-overexpressing SENAs, which were not found after transplantation of WT SENAs.
Methods to purify ES cell-derived cells for transplantation into animal models of neurological diseases
Before differentiated ES cells can be considered for any clinical application, a purification of ES cell-derived cells is required in order to enrich the cellular phenotypes of interest and to remove residual undifferentiated cells. Although ES cells can be efficiently differentiated into a variety of desired cell types in vitro, current differentiation protocols do not generate a homogenous population of cells. As described above, a directed differentiation of ES cells into neuroectodermal cells can significantly enhance the number of functional neurons with specific neurotransmitter profiles in vitro but other neural phenotypes and even cells of other germ layer origins commonly contaminate the final cell population. This finding has an important impact on ES cell-based replacement therapies, since unwanted cellular phenotypes could significantly reduce the efficiency of such approaches. For instance, fetal mesencephalic tissue transplanted into Parkinsonian animals or Parkinson patients can cause side effects such as graft-induced dyskinesia, which has been discussed to be a result of the heterogeneity of engrafted cells and the presence of donor-derived serotoninergic neurons in grafts (Carlsson et al., 2007; Allan et al., 2010) . Most importantly, undifferentiated ES cells can lead to the formation of teratomas consisting of cells of all three germ layers after transplantation. Cell separation methods include immunopanning, magnetic-associated cell sorting (MACS) or fluorescence-activated cell sorting (FACS), which have been applied on differentiated ES cells. Immunopanning of cells is achieved by plating cells on a surface coated with an antibody directed against specific epitopes of interest. By applying this method involving L1 antibody-coated surfaces, mouse ES cell-derived neurons have been isolated at high purity, which formed excitatory and inhibitory synapses and were electrically excitable after replating (Jungling et al., 2003) . Similarly, ES cell-derived neural precursor cells have been efficiently purified after immunopanning for PSA-NCAM (Schmandt et al., 2005) . MACS purification for cell surface molecules has been applied on both, mouse (David et al., 2005) and human ES cell-derived cells and an enrichment for labelled cells was described in these studies. However, the purity of MACS-sorted cells was lower compared to FACS-sorting procedures on the same cell population . Furthermore, a significant enrichment of neural cells was achieved by FACS-sorting differentiated ES cell cultures for single neural cell adhesion molecules such as NCAM (CD56) or CD146 , or for a combination of cell surface antigens including CD15, CD24 and CD29 (Pruszak et al., 2009 ). To determine safety and efficiency of a FACS-sorting procedure for a neural cell adhesion molecule, NCAM-FACS-purified human pluripotent stem cell-derived neural cells were transplanted in an animal model of Parkinson´s disease ). The FACS-purified cells survived and showed functional effects on rotational asymmetry in these animals, while formation of teratomas was not observed. The same study demonstrated that human pluripotent stem cell-derived neurons express the recognition molecule L1 at high levels . Therefore, L1 could also be a suitable candidate molecule for FACS purification experiments with the advantage that postmitotic neurons could also be separated from immature L1-negative but NCAM-positive neural precursor cells and astrocytic cells for transplantation.
Conclusion
In this chapter, we provided examples that an overexpression of recognition molecules in ES cells can influence different aspects of stem cell-mediated regeneration in animal models of acute and chronic neurological disorders including cellular differentiation, migration, recruitment of endogenous neural cells, neuroprotection, and replacement of imperilled host-derived neurons. These findings encourage further investigation of supporting functions of recognition molecules for stem cell-based therapeutic approaches in human diseases. Furthermore, several studies on cell separation of ES cell-derived neurons preventing the formation of teratomas show important progress towards an application of ES cell-derived cells in patients with neurological disorders, and encourage further refinements of these separation techniques for a potential standardized ES cell-based cell therapy.
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